Presented by: Dr. Sumit Subudhi, Medical Oncologist at MD Anderson
Learn more about the LORIKEET study, which is comparing the effectiveness and side effects of potential checkpoint inhibitor treatment given in combination with docetaxel and prednisone with the effectiveness and side effects of docetaxel and prednisone alone for metastatic prostate cancer.
View Patient Summary
Leave a Reply